Introduction: RNA Research Demands Uncompromising Protection
In RNA-based research and manufacturing workflows such as mRNA in vitro transcription, RT-qPCR, and RNA sequencing, even trace levels of RNase contamination can compromise experimental success. Among all RNases, RNase A is particularly abundant and notoriously resistant to standard sterilization methods like autoclaving.
To ensure the stability and integrity of RNA throughout these sensitive processes, Hzymes Biotech offers a GMP-grade Murine RNase Inhibitor—a high-performance, non-animal-origin solution designed for consistent RNase inhibition under stringent conditions.
Why RNase Inhibition Is Critical in RNA Applications
RNases are omnipresent—on lab benches, in pipette tips, tubes, and even on human skin. Their persistence and stability, especially RNase A, pose a significant threat to RNA integrity. In applications such as cDNA synthesis, mRNA production, and polyribosome isolation, uncontrolled RNase activity can lead to RNA degradation and experimental failure.
Preventing this contamination is essential for accurate, reproducible, and scalable RNA workflows. That’s where recombinant murine RNase inhibitors come into play.
Hzymes' Murine RNase Inhibitor: Superior Stability and Performance
Hzymes’ RNase inhibitor is a recombinant murine protein engineered to form a 1:1 complex with RNase A/B/C, effectively neutralizing their activity. Compared to human or porcine RNase inhibitors, murine variants offer enhanced oxidation resistance, making them suitable for applications requiring low DTT concentrations, such as real-time PCR and in vitro transcription reactions.
Key Features:
• High Stability
Remains
active after 10 freeze-thaw cycles
Maintains function after incubation at 55°C for 5 minutes
• High Potency with Less
Enzyme
Strong RNase inhibition with minimal enzyme quantity
Efficient even in complex reaction
systems
• Strict Quality Control Standards
○ Low residual HCP, HCD, metal ions, and endotoxins
○ Nuclease-free, non-animal origin (AOF) certified
○ Manufactured under GMP conditions
• Regulatory Support
○ DMF filing number: MF036854
○ Suitable for use in RNA therapeutics and IVD products
Applications of Hzymes RNase Inhibitor
• mRNA synthesis and vaccine development
• Real-time RT-PCR and qPCR
• cDNA synthesis and RNA isolation
• Polyribosome and ribosome profiling protocols
• Clinical-grade RNA-based product manufacturing
Whether you are developing RNA vaccines or working on gene expression profiling, Hzymes’ murine RNase inhibitor ensures consistent protection against RNase contamination—even under stressful lab conditions.
Performance Validated Under Real Conditions
Our in-house testing demonstrates that Hzymes' RNase inhibitor remains stable after repeated freeze-thaw cycles and short-term thermal stress, delivering reliable RNase suppression throughout.
This product meets the rigorous expectations of both academic researchers and industrial-scale RNA product developers, helping preserve sample quality and maximize experimental reproducibility.
Thermal Stability and Freeze-thaw Stability Test of Hzymes' RNase inhibitor (Murine) The enzyme activity is not affected after freeze-thaw for 10 times or thermostable when incubate at 55°C for 5 mins.
Introduction: RNA Research Demands Uncompromising Protection
In RNA-based research and manufacturing workflows such as mRNA in vitro transcription, RT-qPCR, and RNA sequencing, even trace levels of RNase contamination can compromise experimental success. Among all RNases, RNase A is particularly abundant and notoriously resistant to standard sterilization methods like autoclaving.
To ensure the stability and integrity of RNA throughout these sensitive processes, Hzymes Biotech offers a GMP-grade Murine RNase Inhibitor—a high-performance, non-animal-origin solution designed for consistent RNase inhibition under stringent conditions.
Why RNase Inhibition Is Critical in RNA Applications
RNases are omnipresent—on lab benches, in pipette tips, tubes, and even on human skin. Their persistence and stability, especially RNase A, pose a significant threat to RNA integrity. In applications such as cDNA synthesis, mRNA production, and polyribosome isolation, uncontrolled RNase activity can lead to RNA degradation and experimental failure.
Preventing this contamination is essential for accurate, reproducible, and scalable RNA workflows. That’s where recombinant murine RNase inhibitors come into play.
Hzymes' Murine RNase Inhibitor: Superior Stability and Performance
Hzymes’ RNase inhibitor is a recombinant murine protein engineered to form a 1:1 complex with RNase A/B/C, effectively neutralizing their activity. Compared to human or porcine RNase inhibitors, murine variants offer enhanced oxidation resistance, making them suitable for applications requiring low DTT concentrations, such as real-time PCR and in vitro transcription reactions.
Key Features:
• High Stability
Remains
active after 10 freeze-thaw cycles
Maintains function after incubation at 55°C for 5 minutes
• High Potency with Less
Enzyme
Strong RNase inhibition with minimal enzyme quantity
Efficient even in complex reaction
systems
• Strict Quality Control Standards
○ Low residual HCP, HCD, metal ions, and endotoxins
○ Nuclease-free, non-animal origin (AOF) certified
○ Manufactured under GMP conditions
• Regulatory Support
○ DMF filing number: MF036854
○ Suitable for use in RNA therapeutics and IVD products
Applications of Hzymes RNase Inhibitor
• mRNA synthesis and vaccine development
• Real-time RT-PCR and qPCR
• cDNA synthesis and RNA isolation
• Polyribosome and ribosome profiling protocols
• Clinical-grade RNA-based product manufacturing
Whether you are developing RNA vaccines or working on gene expression profiling, Hzymes’ murine RNase inhibitor ensures consistent protection against RNase contamination—even under stressful lab conditions.
Performance Validated Under Real Conditions
Our in-house testing demonstrates that Hzymes' RNase inhibitor remains stable after repeated freeze-thaw cycles and short-term thermal stress, delivering reliable RNase suppression throughout.
This product meets the rigorous expectations of both academic researchers and industrial-scale RNA product developers, helping preserve sample quality and maximize experimental reproducibility.
Thermal Stability and Freeze-thaw Stability Test of Hzymes' RNase inhibitor (Murine) The enzyme activity is not affected after freeze-thaw for 10 times or thermostable when incubate at 55°C for 5 mins.
Why Choose Hzymes?
With over 20 years of enzyme R&D and manufacturing expertise, Hzymes is committed to advancing high-purity, regulatory-compliant raw materials for molecular diagnostics and RNA therapeutics.
Our RNase inhibitor is backed by:
• ISO9001 / ISO13485 certifications
• GMP-compliant production facilities
• Global DMF registration for regulatory support
Conclusion: Safeguard Your RNA with Confidence
RNA degradation due to RNase contamination is avoidable—with the right tools. Hzymes' GMP-grade Murine RNase Inhibitor offers a powerful, stable, and regulatory-compliant solution to protect your valuable RNA samples across diverse applications.
Why Choose Hzymes?
With over 20 years of enzyme R&D and manufacturing expertise, Hzymes is committed to advancing high-purity, regulatory-compliant raw materials for molecular diagnostics and RNA therapeutics.
Our RNase inhibitor is backed by:
• ISO9001 / ISO13485 certifications
• GMP-compliant production facilities
• Global DMF registration for regulatory support
Conclusion: Safeguard Your RNA with Confidence
RNA degradation due to RNase contamination is avoidable—with the right tools. Hzymes' GMP-grade Murine RNase Inhibitor offers a powerful, stable, and regulatory-compliant solution to protect your valuable RNA samples across diverse applications.
Join Hzymes at Medlab Asia & Asia Health 2025 – Discover High-Performance Diagnostic Enzymes & Molecular Solutions
2025-07-11Optimized Affinity-Based Strategies for High-Integrity mRNA Purification
2025-07-09Optimized Cap 2'-O-Methyltransferase Enables Efficient Cap 1 Formation for High-Quality mRNA Synthesis
2025-07-08Unlocking Efficient mRNA Capping with Hzymes' Vaccinia Virus Capping Enzyme
2025-07-07Please contact on WhatsApp
Service Hotline: +86 400-808-5320
Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China
Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.
Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.
Service Hotline: +86 400-808-5320
Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.
Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.
Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.
Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design
Service Hotline:
+86 400-808-5320Please contact on WhatsApp
MSG